Key result
TRICH score accurately predicts need for ≥3 antihypertensive medications at 3 months after ICH.
Why the study?
Can the TRICH score predict the need for ≥3 antihypertensive medications at 3 months after intracerebral hemorrhage?
Cohort
Yes
Can the TRICH score predict the need for ≥3 antihypertensive medications at 3 months after intracerebral hemorrhage?
Answers are grounded in this paper and cite their sources.
The TRICH score demonstrates good discrimination in predicting the need for triple antihypertensive therapy 3 months post-intracerebral hemorrhage, which may help guide early aggressive blood pressure management.
BACKGROUND AND OBJECTIVES: Poor long-term blood pressure (BP) control due to undertreatment of hypertension is not uncommon after intracerebral hemorrhage (ICH). It heightens the risk of ICH recurrence and subsequent stroke, which is the highest within the first year. Promptly achieving BP targets would significantly reduce these risks. To accomplish this, upfront triple antihypertensive medications could be prescribed soon after ICH because many ICH survivors require ≥3 antihypertensives. However, not all would suit this approach, particularly those with cerebral amyloid angiopathy (CAA), where elevated admission BP may be due to acute hypertensive response rather than underlying hypertension. In addition, overtreatment and excessive BP lowering would cause more side effects and have been associated with increased mortality in older patients. Hence, to facilitate individualized treatment, we aimed to develop a score (TRICH) to predict the need for ≥3 antihypertensives at 3 months after ICH. METHODS: We developed the score using data from the University of Hong Kong prospective ICH registry (2011-2022) and validated it in 3 hospitals (2020-2022) locally. Consecutive patients with spontaneous ICH who survived >90 days and had follow-up BP 3 months after ICH were included. Predictors for needing ≥3 antihypertensive medications at 3 months were identified using multivariate logistic regression, and the score was created using the β-coefficients. DISCUSSION: The TRICH score identifies patients with ICH who need ≥3 antihypertensive medications 3 months after ICH with good discrimination ability. It may guide upfront triple antihypertensive prescription, but further research is warranted, particularly in non-Han Chinese populations.
No takes yet. Share an insight, caveat, or question.
So et al. (2025) conducted a cohort in Intracerebral hemorrhage. TRICH score was evaluated on Need for ≥3 antihypertensive medications at 3 months (p=0.037). The TRICH score identifies patients with intracerebral hemorrhage who need ≥3 antihypertensive medications at 3 months with good discrimination ability.
Synapse has enriched 10 related papers. Consider them for comparative context: